FI97058B - Menetelmä soluissa tuotettavan HIV:n glykoproteiinin GP 160 eristämiseksi ja puhdistamiseksi - Google Patents

Menetelmä soluissa tuotettavan HIV:n glykoproteiinin GP 160 eristämiseksi ja puhdistamiseksi

Info

Publication number
FI97058B
FI97058B FI953141A FI953141A FI97058B FI 97058 B FI97058 B FI 97058B FI 953141 A FI953141 A FI 953141A FI 953141 A FI953141 A FI 953141A FI 97058 B FI97058 B FI 97058B
Authority
FI
Finland
Prior art keywords
cells
produced
isolating
hiv glycoprotein
purifying hiv
Prior art date
Application number
FI953141A
Other languages
English (en)
Swedish (sv)
Other versions
FI953141A0 (fi
FI97058C (fi
FI953141A (fi
Inventor
Johann Eibl
Friedrich Dorner
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of FI953141A0 publication Critical patent/FI953141A0/fi
Publication of FI953141A publication Critical patent/FI953141A/fi
Publication of FI97058B publication Critical patent/FI97058B/fi
Application granted granted Critical
Publication of FI97058C publication Critical patent/FI97058C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
FI953141A 1987-12-23 1995-06-22 Menetelmä soluissa tuotettavan HIV:n glykoproteiinin GP 160 eristämiseksi ja puhdistamiseksi FI97058C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP87119172 1987-12-23
EP87119172A EP0321606B1 (de) 1987-12-23 1987-12-23 Zelluläre amphipatische Proteine in aggregierten Formen und Verfahren zur Herstellung und Reinigung diese Proteine

Publications (4)

Publication Number Publication Date
FI953141A0 FI953141A0 (fi) 1995-06-22
FI953141A FI953141A (fi) 1995-06-22
FI97058B true FI97058B (fi) 1996-06-28
FI97058C FI97058C (fi) 1996-10-10

Family

ID=8197541

Family Applications (2)

Application Number Title Priority Date Filing Date
FI885629A FI96864C (fi) 1987-12-23 1988-12-02 Ei-terapeuttisesti käytettävä HIV:n glykoproteiini GP 160 ja menetelmä sen valmistamiseksi
FI953141A FI97058C (fi) 1987-12-23 1995-06-22 Menetelmä soluissa tuotettavan HIV:n glykoproteiinin GP 160 eristämiseksi ja puhdistamiseksi

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI885629A FI96864C (fi) 1987-12-23 1988-12-02 Ei-terapeuttisesti käytettävä HIV:n glykoproteiini GP 160 ja menetelmä sen valmistamiseksi

Country Status (8)

Country Link
EP (1) EP0321606B1 (fi)
JP (1) JP2656098B2 (fi)
AT (1) ATE95188T1 (fi)
DE (1) DE3787654D1 (fi)
DK (1) DK628188A (fi)
ES (1) ES2059355T3 (fi)
FI (2) FI96864C (fi)
NO (1) NO175782C (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672895B1 (fr) * 1991-02-15 1995-05-12 Transgene Sa Procede de purification d'une proteine fortement glycosylee.
FR2692898B1 (fr) * 1992-06-30 1995-06-02 Centre Nat Rech Scient Procédé d'obtention de protéines membranaires, et utilisation de ces protéines dans un but de diagnostic ou de vaccination.
US5914390A (en) * 1997-05-12 1999-06-22 Celtrix Pharmaceuticals, Inc. Methods for increasing yields of recombinant proteins
DE19939246A1 (de) 1999-08-19 2001-02-22 Phasys Gmbh M Rückfaltung von Membranproteinen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61233700A (ja) * 1984-12-24 1986-10-17 ジエネンテク，インコ−ポレイテツド 分子クロ−ンされたエイズ関連ポリペプチド
CN86100979A (zh) * 1985-02-07 1986-12-17 史密丝克莱恩贝克曼公司 疟疾疫苗的制备方法
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
JPS62198627A (ja) * 1986-02-26 1987-09-02 Biseibutsu Kagaku Kenkyusho:Kk オ−エスキ−病可溶化抗原ワクチン

Also Published As

Publication number Publication date
DE3787654D1 (de) 1993-11-04
FI96864B (fi) 1996-05-31
NO885738D0 (no) 1988-12-23
EP0321606B1 (de) 1993-09-29
NO175782C (no) 1994-12-07
ES2059355T3 (es) 1994-11-16
ATE95188T1 (de) 1993-10-15
FI953141A0 (fi) 1995-06-22
JPH02798A (ja) 1990-01-05
FI96864C (fi) 1996-09-10
DK628188A (da) 1989-06-24
FI97058C (fi) 1996-10-10
NO885738L (no) 1989-06-26
FI953141A (fi) 1995-06-22
NO175782B (no) 1994-08-29
FI885629A0 (fi) 1988-12-02
DK628188D0 (da) 1988-11-10
FI885629A (fi) 1989-06-24
EP0321606A1 (de) 1989-06-28
JP2656098B2 (ja) 1997-09-24

Similar Documents

Publication Publication Date Title
DE69031791D1 (de) Verfahren zur HCV-Züchtung in Zell-Linien aus B- oder T-Lymphozyten
DK0425066T3 (da) Krystallinsk 2-O-alpha-D-glucopyranosyl-L-ascorbinsyre og fremstilling heraf og anvendelser herfor
DE3774751D1 (de) System zum herstellen von kontinuierlichen langen keramischen gegenstaenden.
BR9607571A (pt) Método de utilização de poeiras na redução de minério de ferro
IT8819009A0 (it) Procedimento perfezionato per laproduzione di riso ibrido.
ATE98649T1 (de) Reinigung von lfa-3.
ATE112238T1 (de) Verfahren zur hydrothermalen herstellung von kaliumsilikatlösungen.
ATE54451T1 (de) Verfahren zum isolieren und reinigen von haemin.
ATE236659T1 (de) Entfernen von viren durch ultrafiltration aus proteinlösungen
FI97058B (fi) Menetelmä soluissa tuotettavan HIV:n glykoproteiinin GP 160 eristämiseksi ja puhdistamiseksi
DE68928889D1 (de) Enzymatisches Reinigungsverfahren
ATE133709T1 (de) Peroxidase-gen von mikrobischem ursprung
EP0076696A3 (en) A restriction enzyme and a method for production thereof
PT787007E (pt) Factor anti-inflamatorio metodo de isolamento e utilizacao
DE3882154D1 (de) Verfahren zur herstellung des pres 1/s2/s-hepatitis-b-antigens aus hefe.
FR2691160B1 (fr) Machine de traitement du vin selon la methode champenoise.
DE69024392D1 (de) Verfahren zur Reinigung von Aussenmembran-Protein von Haemophilus influenza
DE69014644D1 (de) Somatische embryogenese von kürbissen.
PT96179A (pt) Processo para a preparacao de 2-acilamino-9-acil-6-halopurinas
IT8122012A0 (it) Processo per la purificazione diprodotti di reazione.
DE69628397D1 (de) Verfahren zur Reinigung von Tamm-Horsfall-Glykoprotein und Uromodulin
PT592574E (pt) Processo de producao de proteinas recombinantes e celulas hospedeiras utilizadas
ES8605693A1 (es) Procedimiento e instalacion para la eliminacion de subproductos industriales, como el aceite de oliva.
IT8722533A0 (it) Processo per depurare acque di scarico.
ATE55257T1 (de) Verfahren zur herstellung von hochgereinigten, hepatitis-b-virus-infektionsfreien gammaglobulinen.

Legal Events

Date Code Title Description
BB Publication of examined application